世界の神経学臨床試験市場は、2022年に約52億4,000万米ドルと評価され、予測期間の2023年から2030年には5.6%以上の健全な成長率で成長すると予測されています。神経学臨床試験とは、神経疾患に対する新しい治療法、薬剤、機器、診断方法の安全性と有効性を評価するために、ヒトを対象に実施される科学的研究です。神経疾患とは、運動、感覚、思考、行動を制御する脳、脊髄、神経に影響を及ぼす疾患を指します。神経学臨床試験市場は、アルツハイマー病、てんかん、脳卒中などの神経疾患の有病率が上昇し、臨床試験や研究活動が活発化しているなどの要因から拡大しています。
世界中で神経疾患の有病率が高まっていることが、市場の成長を促しています。アルツハイマー病国際機構（Alzheimer Disease International Organization）の報告書によると、2020年には世界全体で約5,500万人の認知症患者がおり、この数字は2030年には7,800万人、2050年には1億3,900万人に達すると予測されています。さらに、神経系の臨床試験活動の増加が市場の成長をさらに促進しています。アルツハイマー病協会の記事「アルツハイマー病治療薬開発パイプライン（Alzheimer's Disease Drug Development Pipeline）：2021」によると、アルツハイマー病の治療薬として臨床試験中の医薬品は121件あり、39件のフェーズ3試験が29剤を使用、65剤を含む73件のフェーズ2試験、27剤を含む27件のフェーズ1試験です。また、認知機能の改善を目的とした治験が12剤、行動・精神神経症の治療を目的とした治験が12剤行われています。2020年2月現在、97の医薬品が病気の修正を目的とした試験を実施中です。これらとともに、ClinicalTrials.govによると、2022年6月現在、1,755のてんかんの研究が進行中であることが報告されています。このように、臨床試験活動数の増加が市場成長の原動力となっています。さらに、公的機関による神経学研究への資金提供の増加や、神経学臨床研究サービスを提供するCROのかなりの数が、市場に有利な機会を作り出しています。しかし、神経学臨床試験のコストが高いことが、2023年から2030年の予測期間を通じて市場成長を阻害しています。
神経学臨床試験の世界市場調査において考慮された主要地域は、アジア太平洋、北アメリカ、ヨーロッパ、ラテンアメリカ、中東・アフリカです。北アメリカは、主要な市場プレイヤーの存在、臨床試験に対するFDA承認の増加、同地域における神経疾患の有病率の上昇により、2022年の市場を独占しています。アジア太平洋は、神経疾患の有病率の上昇、臨床試験のための共同研究数の増加、主要企業の地域的拡大、政府機関や非営利団体の市場参入の活発化などの要因により、予測期間中に最も高いCAGRで成長すると予想されます。
本調査の目的は、近年における様々なセグメント・国の市場規模を定義し、今後数年間の価値を予測することです。本レポートは、調査対象国における産業の質的・量的な側面を取り込むように設計されています。
さらに、市場の今後の成長を決定づける推進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競争環境と製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場の潜在的な機会も組み込んでいます。
目次
Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Neurology Clinical Trials Market, by Region, 2020-2030 (USD Billion)
1.2.2. Neurology Clinical Trials Market, by Phase, 2020-2030 (USD Billion)
1.2.3. Neurology Clinical Trials Market, by Study Design, 2020-2030 (USD Billion)
1.2.4. Neurology Clinical Trials Market, by Indication, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Neurology Clinical Trials Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Neurology Clinical Trials Market Dynamics
3.1. Neurology Clinical Trials Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing prevalence of neurological diseases such as Alzheimer's disease, epilepsy, and stroke
3.1.1.2. Growing number of clinical trials and research activities
3.1.2. Market Challenges
3.1.2.1. High Cost of Neurology Clinical Trials
3.1.3. Market Opportunities
3.1.3.1. Increasing funding for neurological studies by public organizations
3.1.3.2. Significant number of CROs providing neurology clinical research services
Chapter 4. Global Neurology Clinical Trials Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter's 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Neurology Clinical Trials Market, by Phase
5.1. Market Snapshot
5.2. Global Neurology Clinical Trials Market by Phase, Performance - Potential Analysis
5.3. Global Neurology Clinical Trials Market Estimates & Forecasts by Phase 2020-2030 (USD Billion)
5.4. Neurology Clinical Trials Market, Sub Segment Analysis
5.4.1. Phase I
5.4.2. Phase II
5.4.3. Phase III
5.4.4. Phase IV
Chapter 6. Global Neurology Clinical Trials Market, by Study Design
6.1. Market Snapshot
6.2. Global Neurology Clinical Trials Market by Study Design, Performance - Potential Analysis
6.3. Global Neurology Clinical Trials Market Estimates & Forecasts by Study Design 2020-2030 (USD Billion)
6.4. Neurology Clinical Trials Market, Sub Segment Analysis
6.4.1. Interventional
6.4.2. Observational
6.4.3. Expanded Access
Chapter 7. Global Neurology Clinical Trials Market, by Indication
7.1. Market Snapshot
7.2. Global Neurology Clinical Trials Market by Indication, Performance - Potential Analysis
7.3. Global Neurology Clinical Trials Market Estimates & Forecasts by Indication 2020-2030 (USD Billion)
7.4. Neurology Clinical Trials Market, Sub Segment Analysis
7.4.1. Epilepsy
7.4.2. Parkinson's Disease (PD)
7.4.3. Huntington's Disease
7.4.4. Stroke
7.4.5. Traumatic Brain Injury (TBI)
7.4.6. Others
Chapter 8. Global Neurology Clinical Trials Market, Regional Analysis
8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Neurology Clinical Trials Market, Regional Market Snapshot
8.4. North America Neurology Clinical Trials Market
8.4.1. U.S. Neurology Clinical Trials Market
8.4.1.1. Phase breakdown estimates & forecasts, 2020-2030
8.4.1.2. Study Design breakdown estimates & forecasts, 2020-2030
8.4.1.3. Indication breakdown estimates & forecasts, 2020-2030
8.4.2. Canada Neurology Clinical Trials Market
8.5. Europe Neurology Clinical Trials Market Snapshot
8.5.1. U.K. Neurology Clinical Trials Market
8.5.2. Germany Neurology Clinical Trials Market
8.5.3. France Neurology Clinical Trials Market
8.5.4. Spain Neurology Clinical Trials Market
8.5.5. Italy Neurology Clinical Trials Market
8.5.6. Rest of Europe Neurology Clinical Trials Market
8.6. Asia-Pacific Neurology Clinical Trials Market Snapshot
8.6.1. China Neurology Clinical Trials Market
8.6.2. India Neurology Clinical Trials Market
8.6.3. Japan Neurology Clinical Trials Market
8.6.4. Australia Neurology Clinical Trials Market
8.6.5. South Korea Neurology Clinical Trials Market
8.6.6. Rest of Asia Pacific Neurology Clinical Trials Market
8.7. Latin America Neurology Clinical Trials Market Snapshot
8.7.1. Brazil Neurology Clinical Trials Market
8.7.2. Mexico Neurology Clinical Trials Market
8.8. Middle East & Africa Neurology Clinical Trials Market
8.8.1. Saudi Arabia Neurology Clinical Trials Market
8.8.2. South Africa Neurology Clinical Trials Market
8.8.3. Rest of Middle East & Africa Neurology Clinical Trials Market
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Company 1
9.1.2. Company 2
9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Supernus Pharmaceuticals, Inc. (Adamas Pharmaceuticals)
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Recent Developments
9.3.2. AstraZeneca
9.3.3. Novartis AG
9.3.4. Eisai Co., Ltd.
9.3.5. Eli Lilly and Company
9.3.6. Aurora Health Care
9.3.7. AbbVie Inc.
9.3.8. Zydus Group
9.3.9. Athira Pharma, Inc.
9.3.10. Annovis Bio Inc.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Neurology Clinical Trials Market, report scope
TABLE 2. Global Neurology Clinical Trials Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Neurology Clinical Trials Market estimates & forecasts by Phase 2020-2030 (USD Billion)
TABLE 4. Global Neurology Clinical Trials Market estimates & forecasts by Study Design 2020-2030 (USD Billion)
TABLE 5. Global Neurology Clinical Trials Market estimates & forecasts by Indication 2020-2030 (USD Billion)
TABLE 6. Global Neurology Clinical Trials Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 7. Global Neurology Clinical Trials Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Neurology Clinical Trials Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Neurology Clinical Trials Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Neurology Clinical Trials Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Neurology Clinical Trials Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Neurology Clinical Trials Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Neurology Clinical Trials Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Neurology Clinical Trials Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. Global Neurology Clinical Trials Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. U.S. Neurology Clinical Trials Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 17. U.S. Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 18. U.S. Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 19. Canada Neurology Clinical Trials Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 20. Canada Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21. Canada Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 22. UK Neurology Clinical Trials Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 23. UK Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24. UK Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 25. Germany Neurology Clinical Trials Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 26. Germany Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27. Germany Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 28. France Neurology Clinical Trials Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 29. France Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30. France Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 31. Italy Neurology Clinical Trials Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 32. Italy Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33. Italy Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 34. Spain Neurology Clinical Trials Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 35. Spain Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36. Spain Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 37. RoE Neurology Clinical Trials Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 38. RoE Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39. RoE Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 40. China Neurology Clinical Trials Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 41. China Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42. China Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 43. India Neurology Clinical Trials Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 44. India Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45. India Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 46. Japan Neurology Clinical Trials Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 47. Japan Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48. Japan Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 49. South Korea Neurology Clinical Trials Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 50. South Korea Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51. South Korea Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 52. Australia Neurology Clinical Trials Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 53. Australia Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54. Australia Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 55. RoAPAC Neurology Clinical Trials Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 56. RoAPAC Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57. RoAPAC Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 58. Brazil Neurology Clinical Trials Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 59. Brazil Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60. Brazil Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 61. Mexico Neurology Clinical Trials Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 62. Mexico Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63. Mexico Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 64. RoLA Neurology Clinical Trials Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 65. RoLA Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66. RoLA Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 67. Saudi Arabia Neurology Clinical Trials Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 68. South Africa Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69. RoMEA Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 70. List of secondary sources, used in the study of global Neurology Clinical Trials Market
TABLE 71. List of primary sources, used in the study of global Neurology Clinical Trials Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
LIST OF FIGURES
FIG 1. Global Neurology Clinical Trials Market, research methodology
FIG 2. Global Neurology Clinical Trials Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Neurology Clinical Trials Market, key trends 2022
FIG 5. Global Neurology Clinical Trials Market, growth prospects 2023-2030
FIG 6. Global Neurology Clinical Trials Market, porters 5 force model
FIG 7. Global Neurology Clinical Trials Market, pest analysis
FIG 8. Global Neurology Clinical Trials Market, value chain analysis
FIG 9. Global Neurology Clinical Trials Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Neurology Clinical Trials Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Neurology Clinical Trials Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Neurology Clinical Trials Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Neurology Clinical Trials Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Neurology Clinical Trials Market, regional snapshot 2020 & 2030
FIG 15. North America Neurology Clinical Trials Market 2020 & 2030 (USD Billion)
FIG 16. Europe Neurology Clinical Trials Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific Neurology Clinical Trials Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Neurology Clinical Trials Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Neurology Clinical Trials Market 2020 & 2030 (USD Billion)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
